Get started
Author

Charlie Chan

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
2020 · Adrian Murray Brunt, Joanne S Haviland, et al. · The Lancet · 1,134
PDF
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
2017 · Charlotte E Coles, Clare L Griffin, et al. · The Lancet · 626
PDF
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT
2023 · Adrian Murray Brunt, Joanne S Haviland, et al. · Health Technology Assessment · 33
PDF
Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study
2025 · A. Murray Brunt, Fay H. Cafferty, et al. · Radiotherapy and Oncology · 31
PDF
Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial
2025 · Anna M Kirby, Laura Finneran, et al. · The Lancet Oncology · 30
PDF
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer
2022 · Milana A. Bergamino, Elena López-Knowles, et al. · EBioMedicine · 25
OC-0101 First results of FAST-Forward phase 3 RCT nodal substudy: 3-year normal tissue effects
2022 · D. Wheatley, J. Haviland, et al. · Radiotherapy and Oncology · 18
PDF
OC-0595: FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy:3-year normal tissue effects
2018 · A.M. Brunt, J. Haviland, et al. · Radiotherapy and Oncology · 16
PDF
Abstract GS4-05: Dose escalated simultaneous integrated boost radiotherapy for women treated by breast conservation surgery for early breast cancer: 3-year adverse effects in the IMPORT HIGH trial (CRUK/06/003)
2019 · CE Coles, CL Griffin, et al. · Cancer Research · 15
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 10-year efficacy and late normal tissue effects from a multicentre, open-label, non-inferiority, phase 3, randomised controlled trial and 5-year efficacy results from a randomised axillary substudy
2026 · Adrian Murray Brunt, Fay H Cafferty, et al. · The Lancet Oncology · 13
5025 Hypofractionated breast radiotherapy for 1 week vs 3 weeks: 10-year efficacy and late normal tissue effects in the FAST-Forward randomised trial
2025 · Adrian M. Brunt, Fay Cafferty, et al. · Radiotherapy and Oncology · 11
Current axillary management of patients with early breast cancer and low-volume nodal disease undergoing primary surgery: results of a United Kingdom national practice survey
2024 · K. Fairhurst, S. A. McIntosh, et al. · Breast Cancer Research and Treatment · 7
PDF
FAST-Forward Phase III Randomised Controlled Trial of 1-Week Hypofractionated Breast Radiotherapy: 5-Year Results for Efficacy and Late Normal Tissue Effects
2020 · A. Murray Brunt, Joanne S. Haviland, et al. · SSRN Electronic Journal · 3
Breform polyester pre-shaped mesh – extending its uses for cancer patients
2016 · Charlie Chan, Fiona Court, et al. · European Journal of Surgical Oncology · 2
P067. Breform polyester mesh for bilateral breast reduction and mastopexy – Early UK experience
2015 · Charlie Chan, Fiona Court, et al. · European Journal of Surgical Oncology · 2
The effect of reconstruction type and radiotherapy on pigment uptake in nipple tattooing
2014 · David Rider, Fiona Court, et al. · European Journal of Surgical Oncology · 2
Intra-operative Sentinel Lymph Node Assessment- How many patients will avoid a second operation?
2012 · Jonathan Horsnell, Hannah Knight, et al. · European Journal of Surgical Oncology · 2
OC-0610: FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 5-year results
2020 · A.M. Brunt, J.S. Haviland, et al. · Radiotherapy and Oncology · 1
5570 Ten-year results of the IMPORT HIGH trial (ISRCTN47437448): Dose escalated simultaneous integrated boost radiotherapy in early breast cancer
2026 · Charlotte E Coles, Lucy Kilburn, et al. · Radiotherapy and Oncology
607 FAST-Forward nodal substudy: 5-year normal tissue effects following 1-week versus 3-week axillary radiotherapy for breast cancer (ISRCTN19906132)
2025 · Adrian M. Brunt, Duncan Wheatley, et al. · Radiotherapy and Oncology
Cosmetic MDT discussion changes management in a significant proportion of aesthetic breast cases
2018 · Charlie Chan, James Bristol, et al. · European Journal of Surgical Oncology
Oncotype DX – changing management in node positive and node negative patients
2016 · Charlie Chan, James Bristol, et al. · European Journal of Surgical Oncology
Postoperative breast imaging surveillance is unaffected by the use of Breform polyester pre-shaped mesh
2016 · Charlie Chan, Fiona Court, et al. · European Journal of Surgical Oncology
Surgeon performed breast ultrasound can accurately diagnose symptomatic breast cancer
2016 · Charlie Chan, James Bristol, et al. · European Journal of Surgical Oncology
P5-16-01: Are We Going To Be Able To Train Future Surgeons How To Perform Axillary Lymph Node Dissection?
2011 · N Betambeau, C Chan · Cancer Research
Works count: 29
Citation count: 3,106
H-index: 11
I10-index: 12
Year
Topic
Type